Noxopharm Ltd (NOX)

Currency in AUD
0.063
+0.004(+6.78%)
Delayed Data·
NOX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.0630.063
52 wk Range
0.0510.110
Key Statistics
Bid/Ask
0.062 / 0.063
Prev. Close
0.059
Open
0.063
Day's Range
0.063-0.063
52 wk Range
0.051-0.11
Volume
14.34K
Average Volume (3m)
85.33K
1-Year Change
-30.7692%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NOX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Short term obligations exceed liquid assets

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Buy
Moving Averages
Neutral

Earnings

Latest Release
Aug 28, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
-303.5K / --
EPS Revisions
Last 90 days

NOX Income Statement

Compare NOX to Peers and Sector

Metrics to compare
NOX
Peers
Sector
Relationship
P/E Ratio
−4.1x−4.1x−0.3x
PEG Ratio
−0.400.000.00
Price/Book
−5.0x2.5x2.6x
Price / LTM Sales
12.7x14.1x3.0x
Upside (Analyst Target)
-254.3%58.5%
Fair Value Upside
Unlock−7.3%7.1%Unlock

Noxopharm Limited, a clinical-stage biotechnology company, engages in the development of therapies for chronic inflammation, autoimmune diseases, and cancer in the Pan-Pacific region. The company develops Sofra, a platform designed to regulate innate immune signaling with greater precision; and Chroma, a small molecule technology platform focused on the development of multiple drug candidates for cancer treatment. It is also developing SOF-SKN, a topical therapy that has completed Phase I clinical trial for cutaneous lupus erythematosus; and CRO-67, a dual-cell preclinical drug candidate for the treatment of pancreatic cancer. In addition, the company intends to improve mRNA vaccines. Noxopharm Limited was incorporated in 2015 and is based in Glenhaven, Australia.

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
14.19M4.62%837.26K
Public Companies & Retail Investors
293.05M95.38%17.29M
Total
307.24M100.00%18.13M

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Rgt Capital Fund No 5 (Noxo) Pty Ltd2.12%6,500,333384
Nora Goodridge Investments Pty Ltd1.01%3,090,489182

FAQ

What Is the Noxopharm (NOX) Stock Price Today?

The Noxopharm stock price today is 0.063 AUD.

What Stock Exchange Does Noxopharm Trade On?

Noxopharm is listed and trades on the Sydney Stock Exchange.

What Is the Stock Symbol for Noxopharm?

The stock symbol for Noxopharm is "NOX."

What Is the Noxopharm Market Cap?

As of today, Noxopharm market cap is 19.360M AUD.

What Is Noxopharm's Earnings Per Share (TTM)?

The Noxopharm EPS (TTM) is -0.015.

From a Technical Analysis Perspective, Is NOX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Noxopharm Stock Split?

Noxopharm has split 1 times.

What is the current trading status of Noxopharm (NOX)?

As of Oct 06, 2026, Noxopharm (NOX) is trading at a price of 0.063 AUD, with a previous close of 0.059 AUD. The stock has fluctuated within a day range of 0.063 AUD to 0.063 AUD, while its 52-week range spans from 0.051 AUD to 0.110 AUD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.